Brochure

DPI Formulation Development And Manufacturing

Lonza 4

Building on particle engineering expertise to optimize respiratory drug delivery and bring advanced therapeutics to market

The respiratory system provides an attractive drug absorption target for both local and systemic disease states and is increasingly utilized for the delivery of both small molecules and biotherapeutics.

Our core particle engineering expertise through milling and/or spray drying is complemented with extensive formulation and process development, specialized relevant characterization tools that allow mechanistic understanding, and encapsulation capabilities to provide integrated respiratory product development from concept through the clinic and commercialization.

Lonza has extensive experience in formulation development and manufacturing of respiratory drug-delivery products from proof of concept (POC) to manufacturing of dry-powder inhaled (DPI) formulations.

VIEW THE BROCHURE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Drug Discovery Online? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: